TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer.

Mitchell S von Itzstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.